Engineered implantable vaccine platform for continuous antigen-specific immunomodulation;
Viswanath, DI, Liu, HC, Capuani, S, Vander Pol, RS, Saunders, SZ, Chua, CYX & Grattoni, A 2022, , Biomaterials, vol. 281, 121374.

Adjuvant chemotherapy in patients with invasive lobular carcinoma and use of the 21-gene recurrence score: A National Cancer Database analysis;
Weiser, R, Polychronopoulou, E, Hatch, SS, Haque, W, Ghani, HA, He, J, Kuo, YF, Gradishar, WJ & Klimberg, VS 2022, , Cancer.

Prognostic and predictive impact of MGMT promoter methylation status in high risk grade II glioma;
Haque, W, Teh, C, Butler, EB & Teh, BS 2022, , Journal of Neuro-Oncology, vol. 157, no. 1, pp. 137-146.

Neoadjuvant Chemotherapy for Metaplastic Breast Cancer: Response Rates, Management, and Outcomes;
Haque, W, Verma, V, Schwartz, MR, Lim, B, Mangalampalli, N, Butler, EB & Teh, BS 2022, , Clinical Breast Cancer.

Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines;
Viswanath, DI, Liu, HC, Huston, DP, Chua, CYX & Grattoni, A 2022, , Biomaterials, vol. 280, 121297.

Advanced strategies to thwart foreign body response to implantable devices;
Capuani, S, Malgir, G, Chua, CYX & Grattoni, A 2022, , Bioengineering and Translational Medicine.

Emerging nanotechnologies in cardiovascular medicine;
Grattoni, A & Cooke, JP 2022, , Nanomedicine: Nanotechnology, Biology, and Medicine, vol. 39, 102472.